drugset / Trial / NCT01128569

Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response

NCT01128569

Phase 2 Completed 52 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

We propose to use an inhaled allergen challenge model to explore the individual contributions of the components of a novel long-acting beta agonist (LABA)/ inhaled corticosteroid (ICS) combination product on protection from allergic triggers in asthma.

Timeline

Start
2010-01
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Furoate Other / unclassified
Comparator Vilanterol Other / unclassified

Indications